Synthesis and SAR of conformationally restricted inhibitors of soluble epoxide hydrolase
- 1 October 2006
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 16 (19) , 5212-5216
- https://doi.org/10.1016/j.bmcl.2006.07.009
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- An Orally Active Epoxide Hydrolase Inhibitor Lowers Blood Pressure and Provides Renal Protection in Salt-Sensitive HypertensionHypertension, 2005
- Optimization of Amide-Based Inhibitors of Soluble Epoxide Hydrolase with Improved Water SolubilityJournal of Medicinal Chemistry, 2005
- Design, Synthesis, and Biological Activity of 1,3-Disubstituted Ureas as Potent Inhibitors of the Soluble Epoxide Hydrolase of Increased Water SolubilityJournal of Medicinal Chemistry, 2004
- Molecular Properties That Influence the Oral Bioavailability of Drug CandidatesJournal of Medicinal Chemistry, 2002
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1Advanced Drug Delivery Reviews, 2001
- Design principles for orally bioavailable drugsDrug Discovery Today, 1996
- VMD: Visual molecular dynamicsJournal of Molecular Graphics, 1996
- Sequence similarity of mammalian epoxide hydrolases to the bacterial haloalkane dehalogenase and other related proteinsFEBS Letters, 1994
- Esterification of N-protected .alpha.-amino acids with alcohol/carbodiimide/4-(dimethylamino)pyridine. Racemization of aspartic and glutamic acid derivativesThe Journal of Organic Chemistry, 1982
- Mammalian Epoxide Hydrases: Inducible Enzymes Catalysing the Inactivation of Carcinogenic and Cytotoxic Metabolites Derived from Aromatic and Olefinic CompoundsXenobiotica, 1973